摘要
Tendinopathies are chronic diseases of an unknown etiology and associated with inflammation.Mesenchymal stem cells(MSCs)have emerged as a viable therapeutic option to combat the pathological progression of tendinopathies,not only because of their potential for multidirectional differentiation and self-renewal,but also their excellent immunomodulatory properties.The immunomodulatory effects of MSCs are increasingly being recognized as playing a crucial role in the treatment of tendinopathies,with MSCs being pivotal in regulating the inflammatory microenvironment by modulating the immune response,ultimately contributing to improved tissue repair.This review will discuss the current knowledge regarding the application of MSCs in tendinopathy treatments through the modulation of the immune response.
基金
supported by the Medical Health Project of the Health Department of Zhejiang Province,grant number 2021KY1045
Ningbo Public Welfare Science and Technology Project,grant number 2021S104
Ningbo Major Science and Technology Project,grant number 2022Z133
Zhejiang Provincial Natural Science Foundation of China,grant number LBY23H180002.
